{"mainPropery":{"diseaseId":10757,"diseaseName":"Exogenous ochronosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10757/exogenous-ochronosis","synonyms":["Ochronosis, acquired"],"synonyms-with-source":[{"name":"Ochronosis, acquired"}],"identifiers":[]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1104184-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4063,"questionText":"What is exogenous ochronosis?","answerText":"<strong>Exogenous ochronosis (EO) </strong>refers&nbsp;to&nbsp;the bluish-black discoloration of areas of the skin, especially the face, ear cartilage, the ocular (eye) tissue, and other body locations.&nbsp; It occurs as the result of exposure to malarial drugs, skin lightening creams and over-exposure the the sun.[15398]&nbsp; Other than the skin discoloration, there are no other health effects. EO does not typically appear until adulthood and may be difficult to diagnose.&nbsp; There is no specific treatment for this condition. Treatment options exist, and include prescription skin creams, vitamins, laser treatments and other skin treatments.&nbsp;  Exogenous ochronosis is different from hereditary ochronosis, which is an inherited condition that occurs with <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/5775/Alkaptonuria.aspx\" target=\"_blank\">alkaptonuria</a>.[15396][15398]","dateModified":"2019-04-29T00:00:00"},"basicQuestions":[],"references":[{"referenceId":15396,"authors":"Vashi N. Kundu R","articleTitle":"Acquired hyperpigmentation disorders","bookWebsiteJournalTitle":"UpToDate","date":"Sept 28, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/acquired-hyperpigmentation-disorders","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15398,"authors":"Bhattar PA, Zawar VP, Godse KV, Patil SP, Nakarni NJ, Gautam MM","articleTitle":"Exogenous Ochronosis","bookWebsiteJournalTitle":"Indian J Derm","date":"Nov-Dec 2015","volume":"60(6)","pages":"537-43","url":"https://www.ncbi.nlm.nih.gov/pubmed/26677264","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":7231,"relatedDiseaseName":"Ochronosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Exogenous_ochronosis"}